期刊文献+

日间不卧床腹膜透析与持续不卧床腹膜透析对心血管并发症的影响 被引量:18

Affects of daytime and continuous ambulatory peritoneal dialysis on cardiovascular complications in patients with ESRD
在线阅读 下载PDF
导出
摘要 目的:比较日间不卧床腹膜透析(DAPD)与持续不卧床腹膜透析(CAPD)对心血管并发症的影响。方法:将2010年6月至12月行PD置管术的64例患者,随机分成CAPD组和DAPD组,每组32例。观察两组患者充血性心力衰竭、恶性高血压等心血管并发症的发生率、发生时间及转归,每半年进行一次容量及心功能的评估,行心脏超声和胸部平片检查,动态观察透析前、透析12月和24月患者心胸比例,左心室内径、左心房内径、左心室壁厚度、右心室内径、室间隔厚度等心血管系统相关指标及血压、透析效能、残余肾肾小球滤过率的变化情况。结果:(1)CAPD组患者1、2年心血管事件发生率为16%、28%,而DAPD组分别为6%和13%(P<0.05),随着透析时间延长,其发生率增加。(2)CAPD与DAPD患者入组时心胸比例无统计学差异,随访至24月CAPD组患者心胸比例明显大于DAPD组(0.51±0.04 vs 0.48±0.05,P<0.05),同时两组左心室内径分别为52.66±6.49 mm,48.69±4.70 mm(P<0.05)。(3)在末次随访中,以血压<140/90 mmHg为标准,CAPD组患者的血压达标率明显低于DAPD组患者(54.2%vs 84.8%,P<0.05)。(4)在透析效能方面,两组溶质清除均充分,且无明显差异。结论:采用DAPD模式的患者较CAPD患者心功能不全发生率低,心胸比例变化小,对心血管系统影响小,可能与容量负荷、残余肾功能状态有关。 Objective: To investigate the cardiovascular complications in daytime ambulatory peritoneal dialysis (DAPD) and continuous ambulatory peritoneal dialysis (CAPD). Methodology:In this prospective study, sixty four patients which received peritoneal dialysis (PD) from June 2010 to December 2010 were enrolled and randomized into group CAPD and group DAPD. The patients with CAPD were treated by using the dialysate 6 ~ 8 L/day, and peritoneal dialysate left in abdomen cavity at night and the patients with DAPD were treated by using the dialysate 6~8L at daytime, and evacuated of dialysate from abdomen at night. The parameters of incidence rate, time and prognosis of congestive heart failure, malignant hypertension and some other cardiovascular complication were observed between two groups. The cardiac function and construct including the dynamic changes of cardiothoracic ratio, left ventricular internal diameter, left atrial diameter,left ventrieular wall thickness, right ventricular diameter, and interventricular septal thickness, were detected by eehocardiography and chest radiograph every 6 month in all patients. Meanwhile, the blood pressure, dialysis adequacy and residual glomerular filtration rate were also investigated. Results: ( 1 ) 1,2-year of the chronic heart failure (CHF) incidence was 16% ,28% in group CAPD, and 6% , 13% in group DAPD respectively (P 〈 0. 05 ). With the extending of time on PD treatment, the CHF incidence was gradually increasing. (2) The CTR had no difference between two groups at baseline,but at the end of follow-up the CTR of group CAPD and DAPD were 0.51±0.04, 0. 48±0.05 respectively (P 〈 0.05 ). The left ventricular internal diameter of group CAPD and DAPD were 52. 66 ~ 6.49,48.69± 4.70 mm respectively,and there was a significant difference ( P 〈 0.05 ). ( 3 ) At the end of follow-up, blood pressure 〈 140/90 mmHg as a standards,the compliance rate of BP was 54. 2% ,84. 8% in group CAPD and DAPD(P 〈0. 05) ,the rate of group CAPD was significantly lower than that of group DAPD. (4) Dialysis adequacy had no difference in two groups. Conclusion:The incidence of cardiovascular complication was lower in DAPD patients, and the change of cardiothoracic ratio was little, which might relate to volume status and residual renal function.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2013年第5期427-433,共7页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 腹膜透析 心血管 透析模式 peritoneal dialysis cardiovascular complications dialysis mode
  • 相关文献

参考文献16

  • 1Sipahioglu MH, Kucuk H, Unal A, et al. Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients. Petit Dial Int,2012,32( 1 ) :73-80.
  • 2Sidhu MS, DeUsperger KC. Cardiovascular problems in dialysis patients : impact on survival. Adv Petit Dial, 2010,26:47 -52.
  • 3Sniderman AD, Solhpour A, Alam A, et al. Cardiovascular death in dialysis patients:lessons we can learn from AURORA. Clin J Am Soc Nephro1,2010,5 (2) :335-340.
  • 4Woodrow G. Volume status in peritoneal dialysis. Petit Dial Int. 2011, 31 ( Suppl 2 ) : S77-82.
  • 5Demirci MS, Demirci C, Ozdogan O, et al. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant ,2011,26(5 ) : 1708-1716.
  • 6Papakrivopoulou E, Booth J, Pinney J, et al. Comparison of volume status in asymptomatic haemodialysis and peritoneal dialysis outpatients. Nephron Extra,2012,2( 1 ) :48-54.
  • 7俞雨生,周岩,张炯,李健东,唐政,季大玺,刘志红,黎磊石.根据残余肾功能状态计算腹膜透析患者透析剂量的临床研究[J].肾脏病与透析肾移植杂志,2009,18(2):115-120. 被引量:17
  • 8van Dijk PC,Jager KJ,de Charro F, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant, 2001,16 ( 6 ) : 1120 - 1129.
  • 9Moraes TP, Pecoits-Filho R, Ribeiro SC, et al. Peritoneal dialysis in Brazil:twenty-five years of experience in a single center. Perit Dial Int ,2009,29(5 ) :492-498.
  • 10俞雨生,周岩,周婷婷,陈伊文,李世军,唐政,刘志红.腹膜透析患者长期生存及相关因素分析——单中心登记系统数据分析[J].肾脏病与透析肾移植杂志,2011,20(3):218-226. 被引量:46

二级参考文献52

共引文献85

同被引文献190

引证文献18

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部